Meet the teens who have lost weight on Ozempic-like drugs — slimming down to stay alive

Deana Buckley wanted her daughter Demi to have a fair shot at happiness. 

Tipping the scales at almost 200 pounds by age 15, the Michigan girl was bullied. 

And despite being a high school athlete — breaking a sweat on the basketball, cheer and volleyball teams — she couldn’t shake the weight. 

“I’d look in the mirror and cry,” Demi, now 16, told The Post. “I truly hated my body.”

But in March 2023, Demi found supportive solace in a syringe — as have other teens faced with similar weight-loss issues.

That January, the Food and Drug Administration approved the use of semaglutide, once-weekly diabetes meds classified as GLP-1 receptor agonists, for obese youngsters 12 and up.